Back

Ependymomas are cancers of the pre-neural crest/roof plate lineage

Balin, P.; Kumar, S. A.; Galton, R.; Delaidelli, A.; Orisme, W.; Haldipur, P.; Mankahla, N.; Saadeldin, A.; von Krosigk, N.; Vladoiu, M. C.; Erickson, A. W.; Barembaum, M.; Millman, J.; Banks, A. J.; Joseph, J. T.; Khan, O.; Du, S.; Sirbu, O.; Ong, W.; Faury, D.; Santa Maria Lopez, V.; Bonner, S.; Coleman, J. C.; Eigenbrood, J.; Cooper, E. A.; Duh, J. K.; Zhang, J.; Lee, J. J.; Rasnitsyn, A.; Cedillo, A. E.; Persad, G.; Hendrikse, L. D.; Saulnier, O.; Van Ommeren, R.; Przelicki, D.; Abeysundara, N.; Curry, R. N.; Ahmed, H. N.; Suarez, R. A.; Richman, C. M.; Huang, N.; Wang, H.; Su, H.; Pallott

2026-07-14 developmental biology
10.64898/2026.07.13.736818 bioRxiv
Show abstract

Distinct molecular variants of the brain cancer ependymoma are distributed along the rostral-caudal extent of the central nervous system (CNS). Historically proposed to arise from ventricular ependyma, recent studies have suggested conflicting cellular origins, including the neural radial glia and the roof plate lineages. Using single-cell transcriptomics, immunohistochemistry, and lineage tracing, we demonstrate that ependymomas across all CNS compartments transcriptionally mirror MSX1+ve pre-neural crest/roof plate (Pre-NC/RP) lineage derivatives. Ependymoma subgroups recapitulate the spatial and molecular diversity of regional Pre-NC/RP populations, while retaining conserved MSX1 expression. Expression of the oncogenic fusion ZFTA-RELA within the murine Pre-NC/RP lineage generated tumors that faithfully resembled human ependymoma. These findings identify a common embryonic cellular origin for ependymomas and reconcile previously conflicting models of tumorigenesis.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 9%
18.3%
2
eLife
5828 papers in training set
Top 15%
7.2%
3
Cell Reports
1498 papers in training set
Top 5%
6.7%
4
Cell
431 papers in training set
Top 1%
5.5%
5
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 10%
5.1%
6
JCI Insight
277 papers in training set
Top 2%
4.0%
7
Nature
645 papers in training set
Top 4%
4.0%
50% of probability mass above
8
Neuro-Oncology
36 papers in training set
Top 0.3%
3.2%
9
Science Advances
1243 papers in training set
Top 11%
3.2%
10
Nature Neuroscience
252 papers in training set
Top 3%
2.6%
11
Science
477 papers in training set
Top 3%
2.6%
12
PLOS ONE
5266 papers in training set
Top 42%
2.4%
13
Neuro-Oncology Advances
25 papers in training set
Top 0.2%
2.4%
14
Advanced Science
286 papers in training set
Top 5%
1.7%
15
Development
497 papers in training set
Top 3%
1.7%
16
EMBO Molecular Medicine
95 papers in training set
Top 1%
1.7%
17
Genome Medicine
183 papers in training set
Top 3%
1.3%
18
Cancer Research
130 papers in training set
Top 2%
1.3%
19
Scientific Reports
3612 papers in training set
Top 66%
1.1%
20
Oncogene
85 papers in training set
Top 1%
1.1%
21
PLOS Biology
486 papers in training set
Top 8%
1.1%
22
Cancer Cell
42 papers in training set
Top 1%
1.0%
23
Journal of Clinical Investigation
179 papers in training set
Top 5%
1.0%
24
Nature Genetics
286 papers in training set
Top 5%
0.8%
25
Genes & Development
90 papers in training set
Top 2%
0.6%
26
Cells
249 papers in training set
Top 9%
0.6%
27
Neuron
337 papers in training set
Top 6%
0.6%
28
Neoplasia
23 papers in training set
Top 1%
0.6%
29
EMBO Reports
263 papers in training set
Top 9%
0.6%